Regeneration of pancreatic islets in vivo by ultrasound-targeted gene therapy.
Gene Ther
; 17(11): 1411-20, 2010 Nov.
Article
en En
| MEDLINE
| ID: mdl-20508600
ABSTRACT
This study uses a novel approach to gene therapy in which plasmid DNA is targeted to the pancreas in vivo using ultrasound-targeted microbubble destruction (UTMD) to achieve islet regeneration. Intravenous microbubbles carrying plasmids are destroyed within the pancreatic microcirculation by ultrasound, achieving local gene expression that is further targeted to ß-cells by a modified rat insulin promoter (RIP3.1). A series of genes implicated in endocrine development were delivered to rats 2 days after streptozotocin-induced diabetes. The genes, PAX4, Nkx2.2, Nkx6.1, Ngn3 and Mafa, produced α-cell hyperplasia, but no significant improvement in ß-cell mass or blood glucose level 30 days after UTMD. In contrast, RIP3.1-NeuroD1 promoted islet regeneration from surviving ß-cells, with normalization of glucose, insulin and C-peptide levels at 30 days. In a longer-term experiment, four of six rats had a return of diabetes at 90 days, accompanied by ß-cell apoptosis on Tunel staining. Pretreatment with the JNK inhibitor SP600125 successfully blocked ß-cell apoptosis and resulted in restoration of ß-cell mass and normalization of blood glucose level for up to 90 days. This technique allows in vivo islet regeneration, restoration of ß-cell mass and normalization of blood sugar, insulin and C-peptide in rats without viruses.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Terapia por Ultrasonido
/
Terapia Genética
/
Islotes Pancreáticos
/
Diabetes Mellitus Experimental
Límite:
Animals
Idioma:
En
Revista:
Gene Ther
Asunto de la revista:
GENETICA MEDICA
/
TERAPEUTICA
Año:
2010
Tipo del documento:
Article
País de afiliación:
Estados Unidos